{"id":128345,"date":"2026-06-24T10:20:58","date_gmt":"2026-06-24T04:50:58","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=128345"},"modified":"2026-06-24T10:20:59","modified_gmt":"2026-06-24T04:50:59","slug":"mangalam-drugs-and-organics-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/","title":{"rendered":"Mangalam Drugs and Organics Share Price Target 2026 Analyst Forecast Bull and Bear Case"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>The Mangalam Drugs and Organics share price target 2026 is Rs 72, implying approximately 20 percent upside from the current market price of Rs 60 (NSE: MANGALAMDR). With Q4 FY26 results released in 2026 and Pharmaceutical APIs and Chemical Intermediates tailwinds in focus, the Rs 72 price objective is supported by the FY27 earnings recovery thesis.<\/em><\/p>\n<p><a href=\"https:\/\/univest.in\/user\/stocks\/mangalam\/mangalam-drugs-and-organics-ltd-share-price-today\">Mangalam Drugs and Organics<\/a> (NSE: MANGALAMDR) is a Pharmaceutical APIs and Chemical Intermediates company trading at Rs 60 with a market capitalisation of Rs 300 crore. Analysts have set the <strong>Mangalam Drugs and Organics share price target<\/strong> at Rs 72 for 2026, based on FY27 earnings projections and sector re-rating potential. This article covers the complete 2026 price forecast including sector tailwinds, key risks, and bull and bear scenarios.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#Mangalam_Drugs_and_Organics_Share_Price_Target_2026_Key_Takeaways\" title=\"Mangalam Drugs and Organics Share Price Target 2026: Key Takeaways\">Mangalam Drugs and Organics Share Price Target 2026: Key Takeaways<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#Mangalam_Drugs_and_Organics_Company_Overview\" title=\"Mangalam Drugs and Organics Company Overview\">Mangalam Drugs and Organics Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#Why_Is_the_Mangalam_Drugs_and_Organics_Share_Price_Target_Set_at_Rs_72_for_2026\" title=\"Why Is the Mangalam Drugs and Organics Share Price Target Set at Rs 72 for 2026\">Why Is the Mangalam Drugs and Organics Share Price Target Set at Rs 72 for 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#FY27_Earnings_Recovery_and_Revenue_Acceleration\" title=\"FY27 Earnings Recovery and Revenue Acceleration\">FY27 Earnings Recovery and Revenue Acceleration<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#Structural_Sector_Tailwinds_in_Pharmaceutical_APIs_and_Chemical_Intermediates\" title=\"Structural Sector Tailwinds in Pharmaceutical APIs and Chemical Intermediates\">Structural Sector Tailwinds in Pharmaceutical APIs and Chemical Intermediates<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\" title=\"RBI Rate Cut Cycle and Lower Cost of Capital\">RBI Rate Cut Cycle and Lower Cost of Capital<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#Union_Budget_2026-27_Capex_Push_and_Policy_Support\" title=\"Union Budget 2026-27 Capex Push and Policy Support\">Union Budget 2026-27 Capex Push and Policy Support<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#FII_Flow_Normalisation_After_the_2026_Tariff_Shock\" title=\"FII Flow Normalisation After the 2026 Tariff Shock\">FII Flow Normalisation After the 2026 Tariff Shock<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#Mangalam_Drugs_and_Organics_Share_Price_Targets_Short_Term_12_Month_and_Long_Term\" title=\"Mangalam Drugs and Organics Share Price Targets: Short Term, 12 Month, and Long Term\">Mangalam Drugs and Organics Share Price Targets: Short Term, 12 Month, and Long Term<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#Short_Term_Mangalam_Drugs_and_Organics_Share_Price_Target\" title=\"Short Term Mangalam Drugs and Organics Share Price Target\">Short Term Mangalam Drugs and Organics Share Price Target<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#12-Month_Mangalam_Drugs_and_Organics_Share_Price_Target_2026\" title=\"12-Month Mangalam Drugs and Organics Share Price Target 2026\">12-Month Mangalam Drugs and Organics Share Price Target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#Long_Term_Mangalam_Drugs_and_Organics_Share_Price_Target_FY27_to_FY28\" title=\"Long Term Mangalam Drugs and Organics Share Price Target: FY27 to FY28\">Long Term Mangalam Drugs and Organics Share Price Target: FY27 to FY28<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#Bull_Case_and_Bear_Case_Scenarios_for_Mangalam_Drugs_and_Organics_in_2026\" title=\"Bull Case and Bear Case Scenarios for Mangalam Drugs and Organics in 2026\">Bull Case and Bear Case Scenarios for Mangalam Drugs and Organics in 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#Bull_Case_Mangalam_Drugs_and_Organics_Share_Price_Target_Rs_87\" title=\"Bull Case Mangalam Drugs and Organics Share Price Target: Rs 87\">Bull Case Mangalam Drugs and Organics Share Price Target: Rs 87<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#Bear_Case_Mangalam_Drugs_and_Organics_Share_Price_Target_Rs_48\" title=\"Bear Case Mangalam Drugs and Organics Share Price Target: Rs 48\">Bear Case Mangalam Drugs and Organics Share Price Target: Rs 48<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#Key_Risks_That_Could_Derail_the_Mangalam_Drugs_and_Organics_2026_Price_Objective\" title=\"Key Risks That Could Derail the Mangalam Drugs and Organics 2026 Price Objective\">Key Risks That Could Derail the Mangalam Drugs and Organics 2026 Price Objective<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#Global_Macro_and_US_Tariff_Headwinds\" title=\"Global Macro and US Tariff Headwinds\">Global Macro and US Tariff Headwinds<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#FY27_Earnings_Miss_and_Guidance_Risk\" title=\"FY27 Earnings Miss and Guidance Risk\">FY27 Earnings Miss and Guidance Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#Competitive_Intensity_Among_Pharmaceutical_APIs_and_Chemical_Intermediates_Peers\" title=\"Competitive Intensity Among Pharmaceutical APIs and Chemical Intermediates Peers\">Competitive Intensity Among Pharmaceutical APIs and Chemical Intermediates Peers<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#Liquidity_Risk_and_FII_Selling_Pressure\" title=\"Liquidity Risk and FII Selling Pressure\">Liquidity Risk and FII Selling Pressure<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#How_to_Invest_in_Mangalam_Drugs_and_Organics\" title=\"How to Invest in Mangalam Drugs and Organics\">How to Invest in Mangalam Drugs and Organics<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#FAQs_on_Mangalam_Drugs_and_Organics_Share_Price_Target_2026\" title=\"FAQs on Mangalam Drugs and Organics Share Price Target 2026\">FAQs on Mangalam Drugs and Organics Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#What_is_the_Mangalam_Drugs_and_Organics_share_price_target_for_2026\" title=\"What is the Mangalam Drugs and Organics share price target for 2026?\">What is the Mangalam Drugs and Organics share price target for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#What_was_the_Mangalam_Drugs_and_Organics_share_price_target_for_2025\" title=\"What was the Mangalam Drugs and Organics share price target for 2025?\">What was the Mangalam Drugs and Organics share price target for 2025?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#Is_Mangalam_Drugs_and_Organics_a_good_investment_at_Rs_60\" title=\"Is Mangalam Drugs and Organics a good investment at Rs 60?\">Is Mangalam Drugs and Organics a good investment at Rs 60?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#What_are_the_key_risks_to_the_Mangalam_Drugs_and_Organics_share_price_target_2026\" title=\"What are the key risks to the Mangalam Drugs and Organics share price target 2026?\">What are the key risks to the Mangalam Drugs and Organics share price target 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#What_is_the_52_week_high_and_low_of_Mangalam_Drugs_and_Organics\" title=\"What is the 52 week high and low of Mangalam Drugs and Organics?\">What is the 52 week high and low of Mangalam Drugs and Organics?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#What_are_the_main_growth_catalysts_for_Mangalam_Drugs_and_Organics_in_2026\" title=\"What are the main growth catalysts for Mangalam Drugs and Organics in 2026?\">What are the main growth catalysts for Mangalam Drugs and Organics in 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#How_does_Mangalam_Drugs_and_Organics_compare_to_its_peers\" title=\"How does Mangalam Drugs and Organics compare to its peers?\">How does Mangalam Drugs and Organics compare to its peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/univest.in\/blogs-2\/mangalam-drugs-and-organics-share-price-target-2026\/#What_is_the_Mangalam_Drugs_and_Organics_share_price_target_for_2027\" title=\"What is the Mangalam Drugs and Organics share price target for 2027?\">What is the Mangalam Drugs and Organics share price target for 2027?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Mangalam_Drugs_and_Organics_Share_Price_Target_2026_Key_Takeaways\"><\/span><strong>Mangalam Drugs and Organics Share Price Target 2026: Key Takeaways<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Mangalam Drugs and Organics share price target 2026:<\/strong> Rs 72 (20% upside from CMP Rs 60)<\/li>\n<li><strong>Bull case:<\/strong> Rs 87 | <strong>Bear case:<\/strong> Rs 48<\/li>\n<li><strong>Ticker:<\/strong> MANGALAMDR | <strong>Sector:<\/strong> Pharmaceutical APIs and Chemical Intermediates | <strong>MCap:<\/strong> Rs 300 crore<\/li>\n<li><strong>52W range:<\/strong> Rs 42 to Rs 104 | <strong>PE:<\/strong> 15x<\/li>\n<li><strong>Key catalyst:<\/strong> Q4 FY26 results and FY27 earnings confirmation in 2026<\/li>\n<li><strong>Key risk:<\/strong> FY27 earnings miss or FII outflows from Indian equities<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Mangalam_Drugs_and_Organics_Company_Overview\"><\/span><strong>Mangalam Drugs and Organics Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Mangalam Drugs and Organics (NSE: MANGALAMDR) is a Mumbai-based manufacturer of pharmaceutical APIs, bulk drugs, and chemical intermediates for domestic formulation companies and export buyers. At CMP Rs 60 against a 52 week range of Rs 42 to Rs 104, the stock trades at a meaningful discount to its 52 week high. Market capitalisation is Rs 300 crore with trailing PE of 15x. Compared to peers in pharma APIs like IOL Chemicals and Laurus Labs, Mangalam Drugs and Organics is positioned as a potential re-rating candidate toward the Rs 72 price objective on FY27 earnings delivery.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Parameter<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>NSE Ticker<\/td>\n<td>MANGALAMDR<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Pharmaceutical APIs and Chemical Intermediates<\/td>\n<\/tr>\n<tr>\n<td>CMP (2026)<\/td>\n<td>Rs 60<\/td>\n<\/tr>\n<tr>\n<td>52 Week High<\/td>\n<td>Rs 104<\/td>\n<\/tr>\n<tr>\n<td>52 Week Low<\/td>\n<td>Rs 42<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 300 crore<\/td>\n<\/tr>\n<tr>\n<td>Trailing PE<\/td>\n<td>15x<\/td>\n<\/tr>\n<tr>\n<td>12-Month Analyst Target<\/td>\n<td>Rs 72<\/td>\n<\/tr>\n<tr>\n<td>Bull Case Target<\/td>\n<td>Rs 87<\/td>\n<\/tr>\n<tr>\n<td>Bear Case Target<\/td>\n<td>Rs 48<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Why_Is_the_Mangalam_Drugs_and_Organics_Share_Price_Target_Set_at_Rs_72_for_2026\"><\/span><strong>Why Is the Mangalam Drugs and Organics Share Price Target Set at Rs 72 for 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Earnings_Recovery_and_Revenue_Acceleration\"><\/span><strong>FY27 Earnings Recovery and Revenue Acceleration<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>Mangalam Drugs and Organics share price target<\/strong> of Rs 72 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results released in 2026 confirming the earnings trajectory are the most direct catalyst for re-rating. The Rs 72 price objective represents the base case with FY27 execution as the key variable.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Structural_Sector_Tailwinds_in_Pharmaceutical_APIs_and_Chemical_Intermediates\"><\/span><strong>Structural Sector Tailwinds in Pharmaceutical APIs and Chemical Intermediates<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Pharmaceutical APIs and Chemical Intermediates sector is expanding on the back of India&#8217;s domestic demand growth, PLI scheme support, and rising corporate investment. Mangalam Drugs and Organics&#8217;s position among peers in pharma APIs like IOL Chemicals and Laurus Labs creates a structural growth runway. Sustained outperformance is one of the key conditions for the Rs 87 bull case to materialise.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\"><\/span><strong>RBI Rate Cut Cycle and Lower Cost of Capital<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s RBI rate cut cycle in 2026 is reducing borrowing costs and stimulating end market demand. Lower interest costs improve Mangalam Drugs and Organics&#8217;s EPS trajectory, narrowing the gap between current earnings and the FY27 estimates that underpin the Rs 72 analyst consensus.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Union_Budget_2026-27_Capex_Push_and_Policy_Support\"><\/span><strong>Union Budget 2026-27 Capex Push and Policy Support<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Budget 2026-27&#8217;s Rs 11.21 lakh crore infrastructure capex and PLI scheme continuity create a favourable backdrop for Mangalam Drugs and Organics&#8217;s Pharmaceutical APIs and Chemical Intermediates operations, improving the probability of achieving the Rs 72 price objective through FY27 earnings delivery.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FII_Flow_Normalisation_After_the_2026_Tariff_Shock\"><\/span><strong>FII Flow Normalisation After the 2026 Tariff Shock<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>As global macro conditions normalise through 2026, FII flows into quality Indian equities are gradually recovering. At 15x PE, Mangalam Drugs and Organics is positioned as a beneficiary of institutional reallocation, providing a tailwind toward the Rs 87 bull case over the medium term.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Mangalam_Drugs_and_Organics_Share_Price_Targets_Short_Term_12_Month_and_Long_Term\"><\/span><strong>Mangalam Drugs and Organics Share Price Targets: Short Term, 12 Month, and Long Term<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Short_Term_Mangalam_Drugs_and_Organics_Share_Price_Target\"><\/span><strong>Short Term Mangalam Drugs and Organics Share Price Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Near-term support for Mangalam Drugs and Organics is anchored close to the 52 week low of Rs 42. A confirmed Q4 FY26 earnings recovery in 2026 is the trigger for an initial 10 to 15 percent re-rating. Investors can use the 52 week low as an entry reference while awaiting FY27 earnings confirmation.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"12-Month_Mangalam_Drugs_and_Organics_Share_Price_Target_2026\"><\/span><strong>12-Month Mangalam Drugs and Organics Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 12-month <strong>Mangalam Drugs and Organics share price target 2026<\/strong> is Rs 72, implying approximately 20 percent upside from CMP Rs 60. This base case assumes in-line FY27 earnings delivery and partial normalisation of FII flows. Track live on NSE ticker MANGALAMDR.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Long_Term_Mangalam_Drugs_and_Organics_Share_Price_Target_FY27_to_FY28\"><\/span><strong>Long Term Mangalam Drugs and Organics Share Price Target: FY27 to FY28<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>long term Mangalam Drugs and Organics share price target<\/strong> for FY27 to FY28 is Rs 87 in the bull case, requiring full earnings delivery, re-rating among peers in pharma APIs like IOL Chemicals and Laurus Labs, and sustained institutional buying over a 2 to 3 year horizon.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bull_Case_and_Bear_Case_Scenarios_for_Mangalam_Drugs_and_Organics_in_2026\"><\/span><strong>Bull Case and Bear Case Scenarios for Mangalam Drugs and Organics in 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Bull_Case_Mangalam_Drugs_and_Organics_Share_Price_Target_Rs_87\"><\/span><strong>Bull Case Mangalam Drugs and Organics Share Price Target: Rs 87<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>bull case Mangalam Drugs and Organics share price target<\/strong> of Rs 87 materialises when FY27 earnings beat analyst estimates, Pharmaceutical APIs and Chemical Intermediates tailwinds accelerate, and FII flows return strongly to Indian equities. From CMP Rs 60, this represents approximately 45 percent potential upside.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Bear_Case_Mangalam_Drugs_and_Organics_Share_Price_Target_Rs_48\"><\/span><strong>Bear Case Mangalam Drugs and Organics Share Price Target: Rs 48<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>bear case Mangalam Drugs and Organics share price target<\/strong> of Rs 48 materialises if FY27 earnings disappoint or FII outflows depress the broader market, risking a test of support near the 52 week low of Rs 42.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Scenario<\/th>\n<th>Target<\/th>\n<th>Key Conditions<\/th>\n<\/tr>\n<tr>\n<td>Bull Case<\/td>\n<td>Rs 87<\/td>\n<td>FY27 beat, sector re-rating, FII inflows<\/td>\n<\/tr>\n<tr>\n<td>Base Case (Analyst Target)<\/td>\n<td>Rs 72<\/td>\n<td>In-line FY27 delivery, partial FII recovery<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 48<\/td>\n<td>FY27 miss, guidance cut, FII outflows persist<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_That_Could_Derail_the_Mangalam_Drugs_and_Organics_2026_Price_Objective\"><\/span><strong>Key Risks That Could Derail the Mangalam Drugs and Organics 2026 Price Objective<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Global_Macro_and_US_Tariff_Headwinds\"><\/span><strong>Global Macro and US Tariff Headwinds<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Prolonged tariff tensions and global demand slowdown remain prominent macro risks to the <strong>Mangalam Drugs and Organics share price target<\/strong> of Rs 72, with FII outflows being the direct transmission mechanism to Indian equity valuations.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Earnings_Miss_and_Guidance_Risk\"><\/span><strong>FY27 Earnings Miss and Guidance Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>An FY27 earnings miss or downward guidance revision would compress valuation multiples. This is the most direct company-specific risk to the Rs 72 analyst price objective. Investors must monitor quarterly results and management commentary closely.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Competitive_Intensity_Among_Pharmaceutical_APIs_and_Chemical_Intermediates_Peers\"><\/span><strong>Competitive Intensity Among Pharmaceutical APIs and Chemical Intermediates Peers<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Intensifying competition from peers in pharma APIs like IOL Chemicals and Laurus Labs could compress Mangalam Drugs and Organics&#8217;s market share and pricing power. This structural risk must be weighed when assessing the defensibility of the earnings trajectory underpinning the Rs 72 analyst target for 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Liquidity_Risk_and_FII_Selling_Pressure\"><\/span><strong>Liquidity Risk and FII Selling Pressure<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Sustained FII outflows from Indian equities can delay the re-rating process regardless of company-level improvement. Investors should maintain position sizing discipline and stop losses to protect capital.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_Mangalam_Drugs_and_Organics\"><\/span><strong>How to Invest in Mangalam Drugs and Organics<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data<\/strong><\/a><\/p>\n<p>Before considering any investment based on the <strong>Mangalam Drugs and Organics share price target<\/strong> of Rs 72, review Q4 FY26 results and FY27 guidance released in 2026. Focus on revenue growth, margin trends, and management commentary on Pharmaceutical APIs and Chemical Intermediates sector demand.<\/p>\n<p>Open a Demat account with a SEBI registered stockbroker to trade Mangalam Drugs and Organics (NSE: MANGALAMDR) with regulatory protection. Study the competitive landscape among peers in pharma APIs like IOL Chemicals and Laurus Labs before executing any position.<\/p>\n<p>Plan your entry using the 52 week low of Rs 42 as a key support reference. A confirmed FY27 earnings uptick validates the entry case for the Rs 72 price objective. Always set a stop loss below the 52 week low.<\/p>\n<p>Restrict any single stock to 3 to 5 percent of your total equity portfolio. Always consult a SEBI registered financial advisor before investing. SEBI Registration No. INH000013776.<\/p>\n<p><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or the <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Mangalam Drugs and Organics&#8217;s live share price and receive daily stock recommendations.<\/em><\/p>\n<div style=\"background: #C0392B; padding: 20px 24px; border-radius: 4px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 15px; font-weight: bold; margin: 0; line-height: 1.7;\"><strong>Disclaimer Note:<\/strong> The securities quoted, if any, are for illustration only and are not recommendatory. This content is for educational purposes only and does not constitute investment advice. Investments in securities are subject to market risk. Read all related documents carefully before investing. SEBI Registration No. INH000013776.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Mangalam_Drugs_and_Organics_Share_Price_Target_2026\"><\/span><strong>FAQs on Mangalam Drugs and Organics Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Mangalam_Drugs_and_Organics_share_price_target_for_2026\"><\/span><strong>What is the Mangalam Drugs and Organics share price target for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Mangalam Drugs and Organics share price target 2026 is Rs 72, implying approximately 20 percent upside from CMP Rs 60. Bull case is Rs 87, bear case is Rs 48.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_Mangalam_Drugs_and_Organics_share_price_target_for_2025\"><\/span><strong>What was the Mangalam Drugs and Organics share price target for 2025?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 2025 price objective for Mangalam Drugs and Organics was based on FY26 earnings projections. The current 2026 analyst consensus is Rs 72, reflecting FY27 growth potential from CMP Rs 60.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Mangalam_Drugs_and_Organics_a_good_investment_at_Rs_60\"><\/span><strong>Is Mangalam Drugs and Organics a good investment at Rs 60?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> At Rs 60, Mangalam Drugs and Organics offers potential upside toward Rs 72 if FY27 earnings recover. Whether this represents a good entry depends on individual risk tolerance. Consult a SEBI registered financial advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_to_the_Mangalam_Drugs_and_Organics_share_price_target_2026\"><\/span><strong>What are the key risks to the Mangalam Drugs and Organics share price target 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key risks to the Mangalam Drugs and Organics share price target of Rs 72 include FY27 earnings miss, global tariff headwinds, FII outflows, and competitive pressure in Pharmaceutical APIs and Chemical Intermediates. Monitoring quarterly results is essential.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_52_week_high_and_low_of_Mangalam_Drugs_and_Organics\"><\/span><strong>What is the 52 week high and low of Mangalam Drugs and Organics?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 52 week high of Mangalam Drugs and Organics is Rs 104 and the 52 week low is Rs 42. At CMP Rs 60, the stock offers potential upside toward the Rs 72 price objective.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_main_growth_catalysts_for_Mangalam_Drugs_and_Organics_in_2026\"><\/span><strong>What are the main growth catalysts for Mangalam Drugs and Organics in 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key catalysts include FY27 PAT recovery, Pharmaceutical APIs and Chemical Intermediates tailwinds, RBI rate cuts in 2026, Budget 2026-27 policy support, and normalisation of FII flows into Indian equities.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Mangalam_Drugs_and_Organics_compare_to_its_peers\"><\/span><strong>How does Mangalam Drugs and Organics compare to its peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Mangalam Drugs and Organics operates in Pharmaceutical APIs and Chemical Intermediates alongside peers in pharma APIs like IOL Chemicals and Laurus Labs. At CMP Rs 60 with MCap Rs 300 crore, it is a potential re-rating candidate toward the Mangalam Drugs and Organics share price target of Rs 72 on FY27 delivery.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Mangalam_Drugs_and_Organics_share_price_target_for_2027\"><\/span><strong>What is the Mangalam Drugs and Organics share price target for 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The long-term Mangalam Drugs and Organics share price target for FY27 to FY28 is Rs 87 in the bull case, assuming earnings growth, sector re-rating, and FII inflows. Consult a SEBI registered financial advisor for personalised guidance.<\/p>\n<div class=\"faq-schema\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>The Mangalam Drugs and Organics share price target 2026 is Rs 72, ~20% upside from CMP Rs 60. Bull Rs 87, bear Rs 48. 2026.<\/p>\n","protected":false},"author":35,"featured_media":128756,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-128345","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1782276663:29"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["78"],"rank_math_title":["Mangalam Drugs and Organics Share Price Target 2026: Rs 72 Analyst Forecast"],"rank_math_description":["The Mangalam Drugs and Organics share price target 2026 is Rs 72, ~20% upside from CMP Rs 60. Bull Rs 87, bear Rs 48. 2026."],"rank_math_focus_keyword":["Mangalam Drugs and Organics share price target"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["128756"],"_edit_last":["29"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["20621"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/06\/Mangalam-Drugs-and-Organics-Share-Price-Target-2026-Analyst-Forecast-Bull-and-Bear-Case.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/128345","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=128345"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/128345\/revisions"}],"predecessor-version":[{"id":128762,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/128345\/revisions\/128762"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/128756"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=128345"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=128345"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=128345"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}